FTI blocks the membrane localization of ras and its signaling pathway by inhibiting the isoprenylation of H-RAS rather than K-RAS, so H-RAS might be a therapeutic target for FTI-mediated reflex sensitization in patients with colorectal cancer [110, 111]. The gene discussed is KRAS; the disease is colorectal cancer.